BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 37 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,773,700 | +25.1% | 10,000,000 | 0.0% | 0.05% | +30.8% |
| Q2 2023 | $7,814,800 | +5.0% | 10,000,000 | 0.0% | 0.04% | +8.3% |
| Q1 2023 | $7,443,800 | +62.1% | 10,000,000 | 0.0% | 0.04% | +63.6% |
| Q4 2022 | $4,590,800 | -22.6% | 10,000,000 | 0.0% | 0.02% | -18.5% |
| Q3 2022 | $5,931,000 | +8.3% | 10,000,000 | 0.0% | 0.03% | +12.5% |
| Q2 2022 | $5,477,000 | -7.7% | 10,000,000 | 0.0% | 0.02% | +9.1% |
| Q1 2022 | $5,936,000 | -19.5% | 10,000,000 | 0.0% | 0.02% | -21.4% |
| Q4 2021 | $7,372,000 | -66.7% | 10,000,000 | -37.5% | 0.03% | -71.1% |
| Q3 2021 | $22,119,000 | +124.5% | 16,000,000 | +166.7% | 0.10% | +115.6% |
| Q2 2021 | $9,853,000 | -0.8% | 6,000,000 | 0.0% | 0.04% | -16.7% |
| Q1 2021 | $9,930,000 | – | 6,000,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 17,000,000 | $16,407,550 | 4.62% |
| BRAIDWELL LP | 114,338,000 | $109,764,480 | 3.47% |
| Castle Creek Arbitrage, LLC | 10,000,000 | $9,635,000 | 2.27% |
| ARISTEIA CAPITAL, L.L.C. | 67,223,000 | $64,534,080 | 1.74% |
| Graham Capital Management, L.P. | 55,529,000 | $53,481,723 | 1.26% |
| 683 Capital Management, LLC | 14,750,000 | $14,186,550 | 1.10% |
| TFG Asset Management GP Ltd | 5,850,000 | $5,622,500 | 1.02% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,875,000 | $21,039,375 | 0.87% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,421,000 | $32,084,160 | 0.75% |
| Context Capital Management, LLC | 6,110 | $5,858 | 0.47% |